Howard J. Weisman - Apr 13, 2023 Form 4 Insider Report for PaxMedica, Inc. (PXMD)

Role
Chief Executive Officer, Director
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Stock symbol
PXMD
Transactions as of
Apr 13, 2023
Transactions value $
$0
Form type
4
Date filed
4/14/2023, 07:12 PM
Previous filing
Mar 9, 2023
Next filing
Apr 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Award $0 +180K +33.23% $0.00 722K Apr 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 180,000 restricted stock units ("RSUs"). The RSUs are subject to time-based vesting with one-third of the RSUs vesting on February 1, 2024, followed by 8.3325% of the remaining RSUs vesting on a quarterly basis thereafter, subject to the reporting person's continuous employment with the Company as of such vesting dates.